Health
Results: 1669-1680 of 8695

Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®

NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services

Nitinotes Receives CE Mark Approval of EndoZip™, the First Fully Automated Suturing System for Endoscopic Sleeve Gastroplasty

Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care







